- Home
- PECO vs AXSM Comparison
PECO vs AXSM Comparison
Compare PECO & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PECO
- AXSM
- Stock Information
- Founded
- PECO 1991
- AXSM 2012
- Country
- PECO United States
- AXSM United States
- Employees
- PECO N/A
- AXSM N/A
- Industry
- PECO Real Estate Investment Trusts
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- PECO Real Estate
- AXSM Health Care
- Exchange
- PECO Nasdaq
- AXSM Nasdaq
- Market Cap
- PECO 4.6B
- AXSM 4.8B
- IPO Year
- PECO 2021
- AXSM 2015
- Fundamental
- Price
- PECO $36.18
- AXSM $104.46
- Analyst Decision
- PECO Buy
- AXSM Strong Buy
- Analyst Count
- PECO 7
- AXSM 15
- Target Price
- PECO $37.67
- AXSM $171.00
- AVG Volume (30 Days)
- PECO 1.0M
- AXSM 912.2K
- Earning Date
- PECO 04-24-2025
- AXSM 05-05-2025
- Dividend Yield
- PECO 3.34%
- AXSM N/A
- EPS Growth
- PECO 6.23
- AXSM N/A
- EPS
- PECO 0.51
- AXSM N/A
- Revenue
- PECO $661,392,000.00
- AXSM $385,693,000.00
- Revenue This Year
- PECO $7.78
- AXSM $63.85
- Revenue Next Year
- PECO $7.13
- AXSM $63.93
- P/E Ratio
- PECO $71.03
- AXSM N/A
- Revenue Growth
- PECO 8.40
- AXSM 42.53
- 52 Week Low
- PECO $30.62
- AXSM $64.11
- 52 Week High
- PECO $40.12
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- PECO 55.01
- AXSM 41.94
- Support Level
- PECO $35.25
- AXSM $86.99
- Resistance Level
- PECO $35.14
- AXSM $103.75
- Average True Range (ATR)
- PECO 1.25
- AXSM 5.84
- MACD
- PECO 0.09
- AXSM -0.01
- Stochastic Oscillator
- PECO 75.52
- AXSM 56.74
About PECO Phillips Edison & Company Inc.
Phillips Edison & Co Inc is a real estate investment trust. The company also operates a third-party investment management business providing property management and advisory services to four unconsolidated institutional joint ventures, in which it has a partial ownership interests, and one private fund. It invests in well-occupied, grocery-anchored neighborhood and community shopping centers. It holds an integrated in-house operating platform built on market of expertise designed to optimize property value and consistently deliver a great shopping experience.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.